189 related articles for article (PubMed ID: 23631630)
1. Improvement in process of care and outcome in patients requiring intensive care unit admission for community acquired pneumonia.
Georges H; Journaux C; Devos P; Alfandari S; Delannoy PY; Meybeck A; Chiche A; Boussekey N; Leroy O
BMC Infect Dis; 2013 Apr; 13():196. PubMed ID: 23631630
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical features and outcomes of hospitalized adult patients with novel influenza A (H1N1) pneumonia and other pneumonia.
Sohn CH; Ryoo SM; Yoon JY; Seo DW; Lim KS; Kim SH; Hong SB; Lim CM; Koh YS; Kim WY
Acad Emerg Med; 2013 Jan; 20(1):46-53. PubMed ID: 23570478
[TBL] [Abstract][Full Text] [Related]
3. [Severe community-acquired pneumonia admitted at the intensive care unit: main clinical and bacteriological features and prognostic factors: a Tunisian experience].
Fekih Hassen M; Ben Haj Khalifa A; Tilouche N; Ben Sik Ali H; Ayed S; Kheder M; Elatrous S
Rev Pneumol Clin; 2014 Oct; 70(5):253-9. PubMed ID: 24874404
[TBL] [Abstract][Full Text] [Related]
4. Severe community-acquired pneumonia.
Restrepo MI; Anzueto A
Infect Dis Clin North Am; 2009 Sep; 23(3):503-20. PubMed ID: 19665080
[TBL] [Abstract][Full Text] [Related]
5. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Palizas F; González M; Apezteguía C; Abroug F; Matamis D; Bugedo G; Esteban A;
J Crit Care; 2005 Sep; 20(3):230-8. PubMed ID: 16253791
[TBL] [Abstract][Full Text] [Related]
6. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough.
Rodriguez A; Lisboa T; Blot S; Martin-Loeches I; Solé-Violan J; De Mendoza D; Rello J;
Intensive Care Med; 2009 Mar; 35(3):430-8. PubMed ID: 19066850
[TBL] [Abstract][Full Text] [Related]
7. Optimizing treatment outcomes in severe community-acquired pneumonia.
de Castro FR; Torres A
Am J Respir Med; 2003; 2(1):39-54. PubMed ID: 14720021
[TBL] [Abstract][Full Text] [Related]
8. There is no "cap" on the importance of community-acquired pneumonia in the ICU.
Shorr AF; Wunderink RG
Chest; 2008 Mar; 133(3):590-2. PubMed ID: 18321897
[No Abstract] [Full Text] [Related]
9. [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia].
Pişkin N; Aydemir H; Oztoprak N; Akduman D; Celebi G; Seremet Keskin A
Mikrobiyol Bul; 2009 Oct; 43(4):597-606. PubMed ID: 20084912
[TBL] [Abstract][Full Text] [Related]
10. Severity assessment in community-acquired pneumonia.
Ewig S; Schäfer H; Torres A
Eur Respir J; 2000 Dec; 16(6):1193-201. PubMed ID: 11292126
[TBL] [Abstract][Full Text] [Related]
11. [Community-acquired pneumonia: a 7-years descriptive study. Usefulness of the IDSA/ATS 2007 in the assessment of ICU admission].
Sabatier C; Peredo R; Villagrá A; Bacelar N; Mariscal D; Ferrer R; Gallego M; Vallés J
Med Intensiva; 2010 May; 34(4):237-45. PubMed ID: 20116135
[TBL] [Abstract][Full Text] [Related]
12. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality.
Restrepo MI; Mortensen EM; Rello J; Brody J; Anzueto A
Chest; 2010 Mar; 137(3):552-7. PubMed ID: 19880910
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia.
Georges H; Leroy O; Vandenbussche C; Guery B; Alfandari S; Tronchon L; Beaucaire G
Intensive Care Med; 1999 Feb; 25(2):198-206. PubMed ID: 10193548
[TBL] [Abstract][Full Text] [Related]
14. Comparison of outcomes and characteristics of patients admitted to the ICU with COVID-19 and other community-acquired pneumonia based on propensity score matching.
Zhao H; Yan X; Guo Z; Li K; Wang Z; Wang J; Lv D; Zhu J; Chen Y
BMC Infect Dis; 2024 Apr; 24(1):419. PubMed ID: 38644489
[TBL] [Abstract][Full Text] [Related]
15. Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients.
Karhu J; Ala-Kokko TI; Ylipalosaari P; Ohtonen P; Laurila JJ; Syrjälä H
Acta Anaesthesiol Scand; 2011 Nov; 55(10):1254-60. PubMed ID: 22092131
[TBL] [Abstract][Full Text] [Related]
16. The role of new therapies for severe community-acquired pneumonia.
Restrepo MI; Anzueto A
Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
[TBL] [Abstract][Full Text] [Related]
17. [Community-acquired pneumonia].
Blanquer J; Sanz F
Arch Bronconeumol; 2010 Oct; 46 Suppl 7():26-30. PubMed ID: 21316547
[TBL] [Abstract][Full Text] [Related]
18. Severe community-acquired pneumonia: an Australian perspective.
Wilson PA; Ferguson J
Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
[TBL] [Abstract][Full Text] [Related]
19. Distinctive features between community-acquired pneumonia (CAP) due to Chlamydophila psittaci and CAP due to Legionella pneumophila admitted to the intensive care unit (ICU).
Gacouin A; Revest M; Letheulle J; Fillatre P; Jouneau S; Piau C; Uhel F; Tattevin P; Le Tulzo Y
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2713-8. PubMed ID: 22538796
[TBL] [Abstract][Full Text] [Related]
20. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database.
Woodhead M; Welch CA; Harrison DA; Bellingan G; Ayres JG
Crit Care; 2006; 10 Suppl 2(Suppl 2):S1. PubMed ID: 16934135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
